Haemophilus Influenzae Type b (Hib) Infection (DBCOND0045329)

Identifiers

Synonyms

Haemophilus Influenzae Type B Infection / Haemophilus Influenzae Type b Diseases / Haemophilus Influenzae Type b Disease / Haemophilus Influenzae Type b Infections / Infectious Disease by Haemophilus Influenzae Type b / Infection caused by Haemophilus Influenzae Type B / Haemophilus influenzae type b infection (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)	Not Annotated	No drug targets
Haemophilus influenzae b polysaccharide-tetanus conjugate	Not Annotated	No drug targets

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06618196	Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age	No drug interventions	prevention	2	not_yet_recruiting
NCT06621654	Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine	No drug interventions	prevention	1	not_yet_recruiting
NCT06605755	Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants	No drug interventions	prevention	Not Available	recruiting
NCT02094833	DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae b polysaccharide-tetanus conjugate Hepatitis B Vaccine (Recombinant) Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	3	completed
NCT03870061	Evaluation of an Infant Immunization Encouragement Program in Nigeria	No drug interventions	prevention	Not Available	completed
NCT04056728	A Phase IV Study to Assess the Safety of EupentaTM Inj	No drug interventions	prevention	4	unknown_status
NCT04073459	Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants	No drug interventions	prevention	2	unknown_status
NCT04978818	Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis fimbriae 2/3 antigen Bordetella pertussis pertactin antigen Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen Hepatitis B Vaccine (Recombinant) Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	4	completed
NCT00654901	Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis pertactin antigen Bordetella pertussis toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae b polysaccharide-tetanus conjugate Hepatitis B Vaccine (Recombinant) Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	3	completed
NCT05457946	Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series	No drug interventions	prevention	2 / 3	not_yet_recruiting
NCT04177485	Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda	No drug interventions	prevention	Not Available	completed
NCT05952596	A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults	No drug interventions	prevention	1	not_yet_recruiting
NCT01404962	Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children	No drug interventions	prevention	4	completed
NCT03208101	A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults	No drug interventions	prevention	1	completed
NCT03341195	Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan	No drug interventions	prevention	Not Available	unknown_status
NCT00158795	Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine	No drug interventions	prevention	4	completed
NCT02560272	Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried	Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen	prevention	3	unknown_status
NCT01019772	Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age	Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	prevention	3	completed
NCT01251133	Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study	Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	prevention	3	completed
NCT01125527	Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children	Clostridium tetani toxoid antigen (formaldehyde inactivated)	prevention	3	completed
NCT01025544	Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China	Aluminium phosphate Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	prevention	3	completed
NCT01226953	Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants	No drug interventions	prevention	3	completed
NCT01044316	Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China	No drug interventions	prevention	3	completed